Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-08-03Clinical Trial Update: Characteristics of Glargine in Type 2 Diabetics [Phase 1]
Phase 1 study evaluating characteristics of insulin glargine in people with Type 2 diabetes. Results were posted in 2015.
-
CLINICAL_TRIALS research · 2015-08-03Clinical Trial Update: An Evaluation of the Effectiveness and Acceptability of Delivering Structured Care in Chinese Type 2 Diabetic Patients [NA]
This clinical trial update evaluates the effectiveness and acceptability of delivering structured care for Chinese patients with Type 2 diab…
-
CLINICAL_TRIALS research · 2015-07-31Clinical Trial Update: Metabolic and Therapeutic Effects of American and Korean Red Ginseng in the Treatment of Type 2 Diabetes [Phase 2]
Phase 2 clinical trial to assess metabolic and therapeutic effects of American and Korean red ginseng in the treatment of type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2015-07-31Clinical Trial Update: Antioxidant Effects of Pomegranate Juice Versus Placebo in Adults With Type 2 Diabetes Mellitus [NA]
Completed clinical trial comparing antioxidant effects of pomegranate juice versus placebo in adults with Type 2 Diabetes Mellitus.
-
CLINICAL_TRIALS trial_result · 2015-07-30Clinical Trial Update: Galvus (Vildagliptin) vs Placebo in Combination With Metformin and Insulin [Phase 4]
A Phase 4 trial evaluated Galvus (vildagliptin) in combination with metformin and insulin versus placebo in adults with Type 2 diabetes mell…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-07-30Clinical Trial Update: Osteoprosis in Type 2 Diabetic Patients- a Cohort Study
A cohort study evaluating osteoporosis in patients with type 2 diabetes mellitus. The sponsor is National Taiwan University Hospital.
-
CLINICAL_TRIALS trial_result · 2015-07-29Clinical Trial Update: An Open Label, Multi-Center, Follow-on Study Examining the Long-Term Safety and Efficacy of Insulin VIAject™ in Subjects With Type 2 Diabetes Mellitus [Phase 3]
This clinical trial update reports the completion of an open-label, multicenter Phase 3 follow-on study evaluating the long-term safety and …
-
FDA approval · 2015-07-28FDA Approved: TRADJENTA — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for Tradjenta (linagliptin) submitted by Boehringer Ingelheim Pharmaceuticals, Inc.
-
FDA label_change · 2015-07-28FDA Approved: JENTADUETO — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for JENTADUETO (linagliptin and metformin HCl) from Boehringer Ingelheim Pharmaceuticals, Inc., sign…
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: The Effect of Administration of Small Doses of Thyroxine on Glucose and Lipid Metabolism, in Type 2 Diabetes Mellitus. [NA]
This completed clinical trial examined the effects of administering small doses of thyroxine on glucose and lipid metabolism in people with …
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: Saxagliptin's Effects on Microalbuminuria Improvement in Type 2 Diabetic Patients [Phase 4]
Phase 4 clinical trial evaluating whether saxagliptin improves microalbuminuria in patients with type 2 diabetes.
-
FDA approval · 2015-07-27FDA Approved: TRULICITY — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for TRULICITY (dulaglutide) from Eli Lilly and Company. The approval updates the product labelin…
-
CLINICAL_TRIALS withdrawal · 2015-07-27Clinical Trial Update: Duodenal Exclusion for the Treatment of Type 2 Diabetes [NA]
Medtronic-sponsored trial of duodenal exclusion for Type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-07-24Clinical Trial Update: A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial comparing dulaglutide with insulin glargine in type 2 diabetes mellitus completed with results posted.
-
CLINICAL_TRIALS trial_result · 2015-07-24Clinical Trial Update: Diabetic Kidney Disease: Influence of Exercise Therapy on Physical and Vascular Function. [NA]
A completed clinical trial evaluating the impact of exercise therapy on physical and vascular function in people with type 2 diabetes-relate…
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin Therapy [Phase 2]
A Phase 2 trial comparing once-daily versus twice-daily empagliflozin (BI 10773) added to metformin in type 2 diabetes reported efficacy and…
-
CLINICAL_TRIALS research · 2015-07-23Clinical Trial Update: The Effects of Jerusalem Artichoke and Fermented Soybean Powder Mixture Supplementation on Glucose Control [NA]
A completed clinical trial evaluated the effects of a Jerusalem artichoke and fermented soybean powder mixture on glucose control in individ…
-
CLINICAL_TRIALS trial_result · 2015-07-22Clinical Trial Update: A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01(Evogliptin/Metformin XR 2.5/500 mg x 2 Tablets) Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg in Healthy Male Volunteers [Phase 1]
Phase 1 trial evaluating the safety, tolerability, and pharmacokinetics of Evogliptin/metformin XR (DA-1229_01) 2.5/500 mg tablets compared …
-
FDA approval · 2015-07-21FDA Approved: PIOGLITAZONE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for pioglitazone hydrochloride (pioglitazone) from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2015-07-21Clinical Trial Update: Effects of Incretin on the Blood Pressure and Lipid in Patients With Overweight or Obese Diabetes [Phase 4]
A Phase 4 clinical trial update assessing whether incretin affects blood pressure and lipid profiles in overweight or obese patients with Ty…
-
CLINICAL_TRIALS research · 2015-07-21Clinical Trial Update: The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a) [Phase 4]
A Phase 4 clinical trial update assessing whether GLP-1 receptor agonists influence blood lipoprotein(a) levels in people with Type 2 diabet…
-
FDA approval · 2015-07-20FDA Approved: TRADJENTA — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for TRADJENTA (linagliptin) from Boehringer Ingelheim Pharmaceuticals, Inc.
-
FDA approval · 2015-07-20FDA Approved: ALOGLIPTIN — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for alogliptin from Padagis Israel Pharmaceuticals Ltd, indicating an update related to the product'…
-
FDA approval · 2015-07-17FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for Lantus SoloStar (insulin glargine) submitted by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2015-07-17Clinical Trial Update: Effect of Dapagliflozine on Systemic and Renal Endothelial Function [Phase 4]
A phase 4 clinical trial update assesses the impact of dapagliflozin on systemic and renal endothelial function in individuals with type 2 d…